Life sciences and healthcare Van Lanschot Kempen

Life Sciences & Healthcare

One-stop shop for European life sciences companies

Life Sciences & Healthcare

Established as the premier, pan-European, specialist investment bank in the Life Sciences & Healthcare sector, Van Lanschot Kempen is a trusted adviser with many repeat clients. We are your one-stop shop with top-tier international expertise and a global investor network. Our Life Sciences & Healthcare team combines in-depth sector knowledge, scientific background and business experience. For corporate clients, our goal is to ensure that all M&A and ECM transaction processes run smoothly, while achieving the best results. For investors, we offer high-quality analysis of the broadest small/mid-cap European life sciences coverage, as well as trade execution and liquidity through our specialised marketing and trading services.

    Unrivalled track record

    Consistently successful results for our clients have led to high levels of repeat business, helping Van Lanschot Kempen build outstanding credentials over the years.

    • Leading pan-European bank for ECM transactions in the life sciences & healthcare sector

    • Outstanding stock-picking track record, consistently beating healthcare indices

    • Connecting EU life sciences companies with global institutional investors

    • Experts in block trades and providing liquidity

    • More than 175 successfully executed transactions, raising over €10 billion

    • Access to both European and US capital markets

    Products and services

    Benefit from our specialist sector knowledge with solutions tailored exclusively to Life Sciences & Healthcare.

    Mergers & acquisitions

    For both listed and private companies, with extensive experience in sell-side and buy-side.

    Corporate advisory

    Buy- and sell-side advisory for cross-border deals, strategic financial advice on capital structuring, and ECM services such as IPOs and public-to-private transactions.

    Equities trading

    Specialists in large (block) trades, orderly venture capital exits and liquidity provision.

    Debt advisory

    Independent advice on debt financing and achievement of optimal capital structures.

    Equities research

    Coverage of approx. 60 listed small/mid-cap companies, providing in-depth analyses based on our in-house sector expertise.

    Equities sales

    Bringing together global investors and European life sciences companies through roadshows, conferences and other access events.

    Equity Capital Markets

    Advice on IPOs and other equity capital markets transactions, such as follow-on capital increases, secondary offerings, share buybacks and equity-linked transactions.

    Transactions

    Great cooperation makes for excellent transactions. Our outstanding sector knowledge combined with a strong focus on understanding stocks and companies ensures we have a superior industry network and distribution power, leading to a successful track record in the market. 

    November 2025
    transgene
    Sole Global Coordinator & Joint Bookrunner
    €105 million
    Accelerated Bookbuild Offering
    Right Arrow in Circle
    See all transactions

    Coverage list

    Curious to know more?

    Jan de Kerpel Van Lanschot Kempen

    Jan De Kerpel

    Managing Director
    Life Sciences & Healthcare

    Emailj.dekerpel@vanlanschotkempen.com
    Nadine Maalouf Van Lanschot Kempen

    Nadine Maalouf

    Managing Director
    Life Sciences & Healthcare
    Portrait of Suzanne van Voorthuizen, employee at Van Lanschot Kempen

    Suzanne van Voorthuizen

    Head of Life Sciences Equity Research